Clinical Trials Browser

Phase 2 × tenofovir alafenamide × Other hematologic neoplasm × Clear all

NCT03804372 2025-02-27

CLL1818

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, Large B-Cell, Diffuse